3 completed. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow NTI164: new trials by email Literature Review of NTI164 trials Research Report on NTI164
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NTI164 Human PK Study NTI164 - Healthy, Healthy Volunteer | Phase 1 | Completed | Fenix Innovation Group | 12 | 2024-02-01 | 2026-09-09 |
| Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Treatment of Rett Syndrome (RTT) NTI164 - Rett Syndrome | Phase 1 / Phase 2 | Completed | Fenix Innovation Group | 14 | 2023-09-20 | 2026-09-09 |
| Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) On Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) NTI164 - PANS Pediatric Acute-Onset Neuropsychiatric Syndrome | Phase 1 / Phase 2 | Completed | Fenix Innovation Group | 18 | 2023-06-02 | 2026-09-09 |
Marijuana Abuse (1) · Pediatric acute-onset neuropsychiatric syndrome (1) · Rett Syndrome (1)
Australia (3)